A YOUNG ADULT WITH GENERALIZED LIPODYSTROPHY AND DIABETES MELLITUS (CASE REPORT)

Area of Science:

• Endocrinology
• Genetics
• Metabolic Disorders

Background:

• Lipodystrophies are rare genetic or acquired conditions characterized by generalized or partial loss of adipose tissue.
• Metabolic complications include severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and hepatic steatosis.

Observation:

• An 18-year-old female presented with new-onset diabetes mellitus, severe hypertriglyceridemia, and elevated transaminases.
• She had a history of recurrent hospitalizations for hypertriglyceridemia since age 8 and developed lipodystrophy at age 11.
• Low leptin levels (1.5 ug/L) were noted, prompting suspicion of lipodystrophy.

Findings:

• Initial treatment with insulin and antihyperlipidemic agents showed limited improvement over two months.
• Initiation of leptin therapy one year after initial hospitalization led to significant improvement in laboratory values.
• This case highlights the diagnostic challenge and therapeutic potential of leptin in lipodystrophy.

Implications:

• Suspecting lipodystrophy in patients with new-onset diabetes mellitus, hypertriglyceridemia, and adipose tissue loss is crucial for timely diagnosis.
• Leptin replacement therapy offers a promising treatment option for managing metabolic complications in lipodystrophy.
• Further research into the genetic and molecular mechanisms of lipodystrophy is warranted to improve patient care.